StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
89
This month
1
This year
5
Publishing Date
2023 - 09 - 21
2
2023 - 05 - 05
1
2023 - 05 - 03
1
2023 - 04 - 19
1
2023 - 04 - 05
1
2023 - 03 - 22
1
2023 - 03 - 08
1
2023 - 03 - 06
1
2023 - 01 - 18
1
2023 - 01 - 13
1
2023 - 01 - 10
1
2022 - 12 - 15
1
2022 - 12 - 07
1
2022 - 11 - 30
1
2022 - 11 - 23
1
2022 - 11 - 04
2
2022 - 10 - 24
1
2022 - 09 - 06
1
2022 - 09 - 02
1
2022 - 08 - 19
1
2022 - 08 - 02
1
2022 - 07 - 13
1
2022 - 06 - 07
1
2022 - 06 - 03
1
2022 - 06 - 02
1
2022 - 05 - 24
1
2022 - 05 - 18
1
2022 - 05 - 11
1
2022 - 04 - 12
1
2022 - 04 - 11
2
2022 - 03 - 28
1
2022 - 03 - 16
1
2022 - 03 - 14
1
2022 - 03 - 08
1
2022 - 03 - 01
1
2022 - 02 - 10
2
2022 - 01 - 18
1
2022 - 01 - 07
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 12
1
2021 - 11 - 05
1
2021 - 09 - 14
1
2021 - 09 - 01
1
2021 - 08 - 31
1
2021 - 08 - 06
1
2021 - 07 - 29
1
2021 - 07 - 27
1
2021 - 07 - 23
1
2021 - 07 - 21
1
2021 - 07 - 12
1
2021 - 06 - 24
1
2021 - 06 - 22
2
2021 - 06 - 16
1
2021 - 06 - 02
1
2021 - 04 - 14
3
2021 - 03 - 09
1
2021 - 02 - 18
1
2021 - 02 - 11
1
2021 - 02 - 04
1
Sector
Commercial services
1
Consumer non-durables
1
Health services
1
Health technology
89
Manufacturing
4
Process industries
1
Professional, scientific, and technical services
1
Technology services
1
Tags
Agreement
25
Alliances
39
Alzheimer's
23
Alzheimer’s
23
Antibody
51
Approval
46
Biomidwest
40
Biopharma
36
Biotech-bay
24
Biotechnology
25
Cancer
139
China
47
Chinese
28
Clinical-trials-phase-iii
32
Collaboration
71
Companies
51
Conference
76
Covid
62
Covid-19
48
Designation
22
Diabetes
57
Disease
89
Drug
105
Earnings
45
Events
32
Expected
24
Fda
71
Financial
65
Financial results
42
Global
149
Growth
108
Health
30
Heart
23
Insulin
37
Iot
23
License
26
Market
306
Meeting
27
Money
34
N/a
1121
Obesity
28
People
70
Pharma
35
Pharmaceutical
24
Phase 1
24
Phase 2
34
Phase 3
47
Positive
30
Report
141
Research
148
Results
203
Risk
24
Study
74
Technology
27
Therapeutics
139
Therapy
88
Tirzepatide
24
Treatment
175
Trial
116
Update
33
Entities
89bio, inc.
1
Abbott laboratories
1
Abbvie inc.
6
Ac immune sa
11
Alnylam pharmaceuticals, inc.
4
Altimmune, inc.
1
Amgen inc.
4
Amicus therapeutics, inc.
1
Anavex life sciences corp.
1
Aptinyx inc.
1
Arrival
1
Astellas pharma inc
1
Astrazeneca plc
6
Bausch health companies inc.
1
Beam therapeutics inc.
1
Biogen inc.
3
Biomarin pharmaceutical inc.
1
Biovie inc.
1
Bristol-myers squibb company
5
Calithera biosciences, inc.
1
Cerner corporation
1
Denali therapeutics inc.
2
Elanco animal health incorporated
1
Eli lilly and company
89
Evotec se
1
Evotec se - adr
1
Galapagos nv
3
Glaxosmithkline plc
7
Hepion pharmaceuticals, inc.
1
Heska corporation
1
Incyte corporation
2
Johnson & johnson
10
Madrigal pharmaceuticals, inc.
1
Metacrine, inc.
1
Mirati therapeutics, inc.
1
Moderna, inc.
1
Neogen corporation
1
Novartis ag
10
Novo nordisk a/s
5
Perrigo company
1
Pfizer, inc.
3
Phibro animal health corporation
1
Qiagen n.v.
1
Quanterix corporation
3
Reata pharmaceuticals, inc.
1
Reckitt benckiser group plc
1
Revolution medicines, inc.
1
Rigel pharmaceuticals, inc.
2
Sanofi
16
Takeda pharmaceutical co ltd
1
Takeda pharmaceutical company limited
6
Teva pharmaceutical industries ltd
4
Thermo fisher scientific inc
1
Vertex pharmaceuticals incorporated
1
Veru inc.
5
Verve therapeutics inc
1
Viatris inc.
2
Vistagen therapeutics, inc.
1
Zoetis inc.
2
Symbols
ABBV
65
ABOS
14
ABT
67
ACIU
21
ALDX
17
ALPMF
16
ALPMY
16
AMGN
26
ANVS
29
ATHA
24
ATHE
14
AVXL
24
AZN
34
AZNCF
23
BBIO
15
BDX
24
BEAM
15
BHC
20
BIIB
74
BIO
16
BIVI
32
BMY
22
BSX
16
CGTX
22
CNTG
23
CYTH
19
DHR
18
DNLI
15
FDMT
14
FNCTF
21
FOLD
20
GANX
20
GBT
33
GILD
20
GLAXF
24
GSK
39
HZNP
23
INCY
16
INMB
16
IONS
14
JNJ
107
LLY
89
MDT
30
MESO
24
NVO
18
NVS
76
NVSEF
61
PFE
28
PHG
15
REGN
16
RGLS
23
SAVA
26
SNY
179
SNYNF
130
TAK
33
TEVJF
36
TMO
47
VRTX
17
VTRS
16
ZVSA
18
Exchanges
Nasdaq
53
Nyse
89
Crawled Date
2023 - 09 - 21
2
2023 - 05 - 05
1
2023 - 05 - 03
1
2023 - 04 - 19
1
2023 - 04 - 05
1
2023 - 03 - 22
1
2023 - 03 - 08
1
2023 - 03 - 06
1
2023 - 01 - 18
1
2023 - 01 - 13
1
2023 - 01 - 10
1
2022 - 12 - 15
1
2022 - 12 - 07
1
2022 - 12 - 01
1
2022 - 11 - 23
1
2022 - 11 - 04
2
2022 - 10 - 24
1
2022 - 09 - 06
1
2022 - 09 - 02
1
2022 - 08 - 19
1
2022 - 08 - 02
1
2022 - 07 - 13
1
2022 - 06 - 07
1
2022 - 06 - 03
1
2022 - 06 - 02
1
2022 - 05 - 24
1
2022 - 05 - 18
1
2022 - 05 - 11
1
2022 - 04 - 12
1
2022 - 04 - 11
2
2022 - 03 - 28
1
2022 - 03 - 16
1
2022 - 03 - 14
1
2022 - 03 - 08
1
2022 - 03 - 01
1
2022 - 02 - 10
2
2022 - 01 - 18
1
2022 - 01 - 07
1
2021 - 11 - 24
1
2021 - 11 - 16
1
2021 - 11 - 12
1
2021 - 11 - 05
1
2021 - 09 - 14
1
2021 - 09 - 01
1
2021 - 08 - 31
1
2021 - 08 - 06
1
2021 - 07 - 29
1
2021 - 07 - 27
1
2021 - 07 - 23
1
2021 - 07 - 21
1
2021 - 07 - 12
1
2021 - 06 - 24
1
2021 - 06 - 22
2
2021 - 06 - 16
1
2021 - 06 - 02
1
2021 - 04 - 14
3
2021 - 03 - 09
1
2021 - 02 - 18
1
2021 - 02 - 11
1
2021 - 02 - 04
1
Crawled Time
00:00
3
01:00
2
02:00
1
03:00
1
05:00
1
07:00
1
08:00
1
10:00
3
11:00
6
12:00
5
12:11
1
12:15
2
12:20
2
12:30
4
13:00
12
13:20
1
14:00
7
14:20
1
15:00
5
15:20
1
15:30
3
16:00
5
17:00
3
18:00
4
19:00
5
21:00
2
22:00
2
22:08
1
23:00
4
Source
www.biospace.com
33
www.globenewswire.com
16
www.prnewswire.com
40
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Disease
symbols :
LLY
save search
Roche granted FDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis
Published:
2024-04-11
(Crawled : 05:00)
- globenewswire.com
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
-2.73%
|
O:
1.06%
H:
0.47%
C:
-0.03%
fda
device
disease
test
granted
blood
designation
for
alzheimer's
roche
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published:
2024-03-13
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-3.27%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
-5.01%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-7.61%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
-3.13%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
News
|
$167.89
0.89%
0.0%
5.6M
|
Health Technology
|
-7.46%
|
O:
0.59%
H:
0.01%
C:
-1.45%
drug
disease
report
research
global
market
Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published:
2024-02-14
(Crawled : 00:00)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-3.33%
|
O:
-2.14%
H:
0.0%
C:
-0.63%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$136.2
-4.19%
1.7K
|
Health Technology
|
12.33%
|
O:
0.87%
H:
0.21%
C:
-2.23%
GSK
|
News
|
$40.59
2.11%
-0.36%
3.8M
|
Health Technology
|
-1.93%
|
O:
0.89%
H:
0.41%
C:
0.1%
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
-1.57%
|
O:
0.38%
H:
2.44%
C:
1.54%
VRTX
|
$400.07
1.47%
1.45%
1.3M
|
Health Technology
|
-4.44%
|
O:
0.56%
H:
0.49%
C:
-0.12%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
0.23%
|
O:
-1.1%
H:
0.0%
C:
0.0%
BIIB
|
$194.1
-0.14%
-0.15%
1.1M
|
Health Technology
|
-14.36%
|
O:
0.16%
H:
0.43%
C:
-2.76%
AZN
|
News
|
$70.12
2.29%
2.24%
4.8M
|
Health Technology
|
14.91%
|
O:
0.28%
H:
0.93%
C:
0.75%
AMGN
|
News
|
$271.98
1.13%
1.12%
2.1M
|
Health Technology
|
-6.39%
|
O:
-0.21%
H:
0.34%
C:
0.07%
disease
report
treatment
expansion
global
infections
market
Animal Therapeutics and Diagnostics Global Market Report 2024 - Dermatological Disease Management in Animals to Propel Market Growth
Published:
2024-02-13
(Crawled : 23:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
ZTS
|
$145.54
-0.66%
0.0%
4.3M
|
Health Technology
|
-20.68%
|
O:
0.93%
H:
0.7%
C:
-0.6%
TMO
|
News
|
$548.38
0.66%
0.29%
1.5M
|
Health Technology
|
1.82%
|
O:
0.56%
H:
1.3%
C:
1.22%
QGEN
|
$41.22
3.05%
0.0%
1.2M
|
Health Technology
|
-3.83%
|
O:
-1.14%
H:
1.3%
C:
1.2%
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
-1.57%
|
O:
0.38%
H:
2.44%
C:
1.54%
ELAN
|
$12.93
-0.15%
0.0%
4.8M
|
Process Industries
|
-17.59%
|
O:
1.53%
H:
1.16%
C:
0.82%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
0.23%
|
O:
-1.1%
H:
0.0%
C:
0.0%
QGEN
|
$41.22
3.05%
0.0%
1.2M
|
Health Technology
|
-3.83%
|
O:
-1.14%
H:
1.3%
C:
1.2%
PAHC
|
$13.06
-1.81%
-1.84%
93K
|
Health Technology
|
15.18%
|
O:
1.32%
H:
4.7%
C:
4.09%
NEOG
P
|
$11.775
1.42%
1.4%
2.1M
|
Health Technology
|
-28.35%
|
O:
-0.24%
H:
4.39%
C:
3.29%
management
propel
disease
report
animal
global
animals
dermatological
diagnostics
therapeutics
growth
market
Non-Alcoholic Fatty Liver Disease Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - MediciNova, Eli Lilly and Company, AstraZeneca, Madrigal Pharmaceuticals, BioMarin Pharmaceutical, GlaxoSmithKline, Pfizer
Published:
2024-01-22
(Crawled : 22:00)
- prnewswire.com
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
15.92%
|
O:
-0.51%
H:
0.37%
C:
0.32%
MDGL
|
$213.85
0.85%
0.85%
720K
|
Health Technology
|
-8.44%
|
O:
1.29%
H:
0.35%
C:
-3.04%
HEPA
|
$1.45
-27.86%
-38.62%
320K
|
Health Technology
|
-32.54%
|
O:
-0.48%
H:
7.69%
C:
1.44%
ALT
|
$7.48
8.25%
7.62%
2.3M
|
Commercial Services
|
-25.6%
|
O:
-0.8%
H:
6.02%
C:
0.6%
ALNY
|
$145.78
0.95%
0.94%
390K
|
Health Technology
|
-20.73%
|
O:
0.46%
H:
3.04%
C:
2.67%
ETNB
|
$9.31
2.53%
2.47%
580K
|
Health Technology
|
-14.74%
|
O:
1.19%
H:
0.63%
C:
-0.72%
liver
disease
companies
key
growth
market
AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial
Published:
2023-12-15
(Crawled : 12:30)
- globenewswire.com
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-4.73%
|
O:
-0.39%
H:
0.0%
C:
0.0%
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
23.19%
|
O:
-4.44%
H:
0.0%
C:
0.0%
ACIU
|
$2.425
2.75%
2.68%
210K
|
Health Technology
|
-34.77%
|
O:
-1.62%
H:
9.04%
C:
7.4%
disease
active
alzheimer’s
immunotherapy
trial
Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published:
2023-12-06
(Crawled : 15:30)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
14.62%
|
O:
1.64%
H:
0.0%
C:
-1.33%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
-2.27%
|
O:
0.52%
H:
0.18%
C:
-0.43%
GSK
|
News
|
$40.59
2.11%
-0.36%
3.8M
|
Health Technology
|
11.73%
|
O:
-0.03%
H:
0.28%
C:
-0.41%
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
25.47%
|
O:
0.99%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.89
0.89%
0.0%
5.6M
|
Health Technology
|
16.13%
|
O:
0.26%
H:
0.0%
C:
0.0%
DNLI
|
$15.99
-0.06%
-0.06%
3.1M
|
Health Technology
|
-13.75%
|
O:
0.05%
H:
5.74%
C:
3.18%
BIIB
|
$194.1
-0.14%
-0.15%
1.1M
|
Health Technology
|
-15.45%
|
O:
0.42%
H:
2.37%
C:
1.45%
disease
parkinson's
revenue
research
therapeutics
market
AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer’s Disease as a Surrogate of Clinical Efficacy on November 9, 2023
Published:
2023-11-02
(Crawled : 11:00)
- globenewswire.com
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
32.35%
|
O:
4.42%
H:
0.0%
C:
0.0%
ACIU
|
$2.425
2.75%
2.68%
210K
|
Health Technology
|
-16.26%
|
O:
-1.38%
H:
0.0%
C:
0.0%
disease
alzheimer’s
imaging
Beam Announces Agreement for Lilly to Acquire Beam’s Opt-In Rights to Verve Therapeutics’ Base Editing Programs for Cardiovascular Disease
Published:
2023-10-31
(Crawled : 10:00)
- globenewswire.com
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
28.65%
|
O:
-0.03%
H:
0.0%
C:
0.0%
BEAM
|
$24.13
0.96%
0.95%
2.1M
|
Health Technology
|
26.11%
|
O:
7.69%
H:
7.3%
C:
2.72%
disease
acquire
cardiovascular
agreement
Redwire Announces First Spaceflight Mission for New Cutting-Edge Pharmaceutical Drug Development Lab, Partnering with Eli Lilly and Company to Expand Space Research to Study Heart Disease and Diabetes
Published:
2023-10-30
(Crawled : 13:00)
- biospace.com/
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
29.54%
|
O:
0.69%
H:
0.0%
C:
0.0%
drug
disease
company
space
research
heart
diabetes
study
AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic
Published:
2023-10-27
(Crawled : 11:00)
- globenewswire.com
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
26.83%
|
O:
-2.09%
H:
0.0%
C:
0.0%
ACIU
|
$2.425
2.75%
2.68%
210K
|
Health Technology
|
-16.26%
|
O:
-10.03%
H:
0.0%
C:
0.0%
aci-1258
aci-12589
disease
alpha-synuclein
diagnostic
communications
neurodegenerative
potential
show
Lilly's Mirikizumab Helped Patients with Crohn's Disease Achieve Long-Term Remission in Phase 3 Trial
Published:
2023-10-12
(Crawled : 13:00)
- biospace.com/
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
20.83%
|
O:
0.54%
H:
0.0%
C:
0.0%
disease
trial
US FDA approves Jardiance® for the treatment of adults with chronic kidney disease
Published:
2023-09-22
(Crawled : 15:00)
- biospace.com/
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
29.36%
|
O:
-2.93%
H:
1.22%
C:
0.32%
jardiance
fda
disease
kidney
treatment
Conquering Challenges in the Solid Tumor Market: Your Guide to FDA-EMA Indications, Regulatory Compliance, and Market Access Excellence | Disease Landscape Insights
Published:
2023-09-21
(Crawled : 15:30)
- prnewswire.com
AZNCF
|
News
|
$136.2
-4.19%
1.7K
|
Health Technology
|
1.75%
|
O:
-1.13%
H:
0.0%
C:
-0.63%
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-7.8%
|
O:
0.52%
H:
0.57%
C:
-0.56%
GSK
|
News
|
$40.59
2.11%
-0.36%
3.8M
|
Health Technology
|
6.62%
|
O:
-0.5%
H:
0.26%
C:
-0.69%
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
27.46%
|
O:
-1.47%
H:
0.0%
C:
0.0%
BMY
|
$49.14
0.43%
0.0%
7.9M
|
Health Technology
|
-16.4%
|
O:
-0.37%
H:
1.54%
C:
0.89%
ABBV
|
News
|
$167.89
0.89%
0.0%
5.6M
|
Health Technology
|
9.2%
|
O:
-0.04%
H:
0.76%
C:
-0.16%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-16.49%
|
O:
-1.16%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.12
2.29%
2.24%
4.8M
|
Health Technology
|
3.19%
|
O:
0.19%
H:
0.03%
C:
-1.57%
AMGN
|
News
|
$271.98
1.13%
1.12%
2.1M
|
Health Technology
|
0.17%
|
O:
0.22%
H:
0.15%
C:
-0.98%
disease
tumor
market
Reshaping Oncology Research and Consulting services: How DLI Empowers Every Step of the Journey | Disease Landscape Insights
Published:
2023-09-21
(Crawled : 08:00)
- prnewswire.com
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
27.46%
|
O:
-1.47%
H:
0.0%
C:
0.0%
disease
research
Insights Into the Global Alzheimer's Disease Market, 2023-2032 - Eli Lilly's Donanemab Poised as Front-Runner for 2024 Market Debut, Set to Rival Biogen and Eisai's LEQEMBI in Emerging Therapy Arena
Published:
2023-08-18
(Crawled : 19:00)
- prnewswire.com
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
leqembi
disease
global
alzheimer's
set
therapy
market
Jardiance® (empagliflozin) approved in the EU for the treatment of adults with chronic kidney disease
Published:
2023-07-25
(Crawled : 13:00)
- biospace.com/
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
59.22%
|
O:
-0.34%
H:
0.69%
C:
-0.05%
jardiance
disease
kidney
approved
treatment
Allen Institute for Immunology partners with Lilly to better understand autoimmune disease
Published:
2023-07-18
(Crawled : 18:00)
- biospace.com/
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
63.56%
|
O:
-0.04%
H:
1.43%
C:
0.95%
institute
disease
immunology
Lilly Announces Webcast to Provide Alzheimer's Disease Update at AAIC
Published:
2023-07-11
(Crawled : 18:00)
- biospace.com/
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
61.38%
|
O:
-0.7%
H:
0.12%
C:
-2.36%
disease
update
alzheimer's
aaic
Chronic Kidney Disease - Market Insight, Epidemiology and Market Forecast 2023-2032: With Focus on United States, EU4 (Germany, Spain, Italy, and France), the United Kingdom, and Japan
Published:
2023-06-28
(Crawled : 02:00)
- prnewswire.com
NVO
|
News
|
$125.26
2.08%
0.18%
3.6M
|
Health Technology
|
-19.69%
|
O:
1.47%
H:
0.0%
C:
-0.94%
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
57.44%
|
O:
0.86%
H:
0.0%
C:
-2.09%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-13.62%
|
O:
0.75%
H:
0.0%
C:
0.0%
RETA
|
$172.36
0.02%
0.03%
0
|
Health Technology
|
86.56%
|
O:
6.1%
H:
5.34%
C:
0.82%
disease
japan
kidney
market
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
75%
25%
Top 10 Gainers
MTTR
|
News
M
|
$4.78
174.71%
63.6%
72M
|
AGBA
|
$2.565
105.2%
51.27%
200M
|
Finance
MLEC
|
$2.44
74.29%
42.62%
78M
|
n/a
EDBL
|
News
|
$6.28
67.02%
40.13%
16M
|
ATGL
|
$2.91
48.81%
32.8%
180K
|
ZAPP
|
$0.2175
47.16%
32.05%
16M
|
n/a
ONFO
|
$0.6075
38.38%
27.74%
7.3M
|
n/a
VIVK
|
$1.48
38.32%
27.7%
530K
|
Professional, Scientific, and T...
MNTS
|
$0.5
35.69%
26.3%
4.8M
|
SDIG
A
|
$3.635
35.13%
26.0%
1M
|
Your saved searches
Save your searches and get alerts when important news are released.